Published in Malar J on November 04, 2016
Repellents as Added Control Measure to Long Lasting Insecticidal Nets (MalaResT) | NCT01663831
Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities. PLoS One (2017) 0.76
Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana. PLoS One (2017) 0.75
Analytical Tools to Improve Optimization Procedures for Lateral Flow Assays. Diagnostics (Basel) (2017) 0.75
Multiple significance tests: the Bonferroni method. BMJ (1995) 23.46
Malaria. Lancet (2005) 7.37
The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet (2013) 6.70
Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A (2005) 6.39
A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis (2012) 5.24
Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species. Mol Microbiol (2000) 3.70
Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol (1998) 3.66
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
Targeting asymptomatic malaria infections: active surveillance in control and elimination. PLoS Med (2013) 3.23
Estimating equations for association structures. Stat Med (2004) 3.21
Malaria transmission and major malaria vectors in different geographical areas of Southeast Asia. Trop Med Int Health (2004) 2.98
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors. Malar J (2007) 2.75
New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis (2012) 2.52
Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47
Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. PLoS Pathog (2010) 2.30
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J (2007) 2.30
Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One (2011) 2.18
Spatial and temporal epidemiology of clinical malaria in Cambodia 2004-2013. Malar J (2014) 2.12
The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog (2010) 2.03
Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv Parasitol (2009) 1.96
Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin Diagn Lab Immunol (1995) 1.92
Malaria diagnosis: a brief review. Korean J Parasitol (2009) 1.86
Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol (1994) 1.72
Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS One (2008) 1.61
Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens. Clin Vaccine Immunol (2006) 1.55
An innovative tool for moving malaria PCR detection of parasite reservoir into the field. Malar J (2013) 1.40
Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease. Annu Rev Immunol (2014) 1.38
Dynamics of the antibody response to Plasmodium falciparum infection in African children. J Infect Dis (2014) 1.32
Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J (2012) 1.27
OutlierD: an R package for outlier detection using quantile regression on mass spectrometry data. Bioinformatics (2008) 1.25
Plasmodium knowlesi infection in humans, Cambodia, 2007-2010. Emerg Infect Dis (2011) 1.23
Measurement of Plasmodium falciparum transmission intensity using serological cohort data from Indonesian schoolchildren. Malar J (2013) 1.20
Serological measures of malaria transmission in Haiti: comparison of longitudinal and cross-sectional methods. PLoS One (2014) 1.14
Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009. Malar J (2014) 1.14
Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. Am J Trop Med Hyg (2006) 1.13
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A (2015) 1.13
Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains. PLoS Negl Trop Dis (2013) 1.13
Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria. Infect Immun (2002) 1.12
A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens. Malar J (2010) 1.11
Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Vaccine (2000) 1.09
Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti. Malar J (2014) 1.09
How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends Parasitol (2013) 1.07
Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets? Mol Biochem Parasitol (2009) 1.07
Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes. PLoS One (2011) 1.07
Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands. BMC Infect Dis (2012) 1.07
De novo assembly of a field isolate genome reveals novel Plasmodium vivax erythrocyte invasion genes. PLoS Negl Trop Dis (2013) 1.07
Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J Infect Dis (2014) 1.07
Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Infect Immun (2014) 1.06
Spatial clustering and risk factors of malaria infections in Ratanakiri Province, Cambodia. Malar J (2014) 1.02
Serology describes a profile of declining malaria transmission in Farafenni, The Gambia. Malar J (2015) 0.95
Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep (2014) 0.94
Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax. PLoS One (2011) 0.93
Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation. Malar J (2014) 0.92
Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens. Malar J (2012) 0.90
Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays. Parasit Vectors (2011) 0.90
Plasmodium vivax and Plasmodium falciparum infections in the Republic of Djibouti: evaluation of their prevalence and potential determinants. Malar J (2012) 0.89
High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea. Infect Genet Evol (2010) 0.88
Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity. Sci Rep (2016) 0.87
Malaria elimination without stigmatization: a note of caution about the use of terminology in elimination settings. Malar J (2014) 0.85
Trying to remember: immunological B cell memory to malaria. Trends Parasitol (2015) 0.85
Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: a cluster randomised controlled trial. Lancet Infect Dis (2016) 0.84
Living on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus. PLoS Comput Biol (2012) 0.84
Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library. Malar J (2014) 0.83
Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population. Malar J (2013) 0.80
Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar J (2015) 0.79
Analysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIX™). Malar J (2015) 0.78
Outlier detection using projection quantile regression for mass spectrometry data with low replication. BMC Res Notes (2012) 0.77
Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia. Malar J (2016) 0.79
Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting. Sci Rep (2016) 0.76
Passive case detection of malaria in Ratanakiri Province (Cambodia) to detect villages at higher risk for malaria. Malar J (2017) 0.75
The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria. Sci Rep (2016) 0.75
Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions. PLoS Negl Trop Dis (2017) 0.75
Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development. Elife (2017) 0.75